Later this month, TMX Equicom will be releasing its 2011 Year-End Healthcare Report, our annual in-depth study of the Canadian life sciences sector. In advance of that release, here are some key preliminary figures from the report shedding light on sector financings for 2011:

• Gross proceeds of equity and convertible debt financings completed in Q4 2011 totaled $98M
• For 2011, the total gross proceeds for development-stage healthcare companies was $471M, compared to $498M in 2010 and $538M in 2009, down ~50% from the average raised during 2005-07

Check back here, or at equicomgroup.com, later this month for access to the full report, which will feature the following:

• Review of all major events from Q4 2011 in the Canadian Healthcare Sector 
• Comprehensive breakdown of all financings from 2011
• December 2011 survey results on the perception of Buyside and Retail contacts active in the healthcare space
• A look ahead at anticipated milestone events for 2012